PerCP anti-human CD8a | BioLegend 300922 product information

product summary

company name :

BioLegend

other brands :

Babco, Signet, Sternberger Monoclonals, Senetek, Covance

product type :

antibody

product name :

PerCP anti-human CD8a

catalog :

300922

quantity :

100 tests

price :

335 USD

clonality :

monoclonal

host :

mouse

conjugate :

PerCP

clone name :

Hit8a

reactivity :

human

application :

flow cytometry

more info or order :

BioLegend product webpage

citations: 16

Published Application/Species/Sample/Dilution	Reference
flow cytometry; human; loading ...; fig 5a	Chen Y, Feng R, He B, Wang J, Xian N, Huang G, et al. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma. Front Mol Biosci. 2021;8:777370 pubmed publisher
flow cytometry; human; 1:100	Wang Q, Gao H, Clark K, Mugisha C, Davis K, Tang J, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371: pubmed publisher
flow cytometry; human; loading ...; fig 4	Heath J, Newhook N, Comeau E, Gallant M, Fudge N, Grant M. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence. J Immunol Res. 2016;2016:7470124 pubmed publisher
flow cytometry; human	Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
	Hamdan F, Feodoroff M, Russo S, Fusciello M, Feola S, Chiaro J, et al. Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses. Mol Ther Oncolytics. 2023;28:264-276 pubmed publisher
	Wang S, Zhang X, Zou X, Wen M, Gan C, Jiang X, et al. Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells. Cancer Immunol Immunother. 2023;72:1301-1313 pubmed publisher
	Li P, Yuan W, Wu R, Zeng C, Li K, Lu L. Androgens in Patients With Luminal B and HER2 Breast Cancer Might Be a Biomarker Promoting Anti-PD-1 Efficacy. Front Oncol. 2022;12:917400 pubmed publisher
	Kim M, Jayasinghe R, Devenport J, Ritchey J, Rettig M, O Neal J, et al. A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity. Nat Commun. 2022;13:3296 pubmed publisher
	Kashima Y, Kaneko K, Reteng P, Yoshitake N, Runtuwene L, Nagasawa S, et al. Intensive single-cell analysis reveals immune-cell diversity among healthy individuals. Life Sci Alliance. 2022;5: pubmed publisher
	Holder K, Burt K, Grant M. TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4+ T cells. Clin Transl Immunology. 2021;10:e1348 pubmed publisher
	Hamdan F, Ylösmäki E, Chiaro J, Giannoula Y, Long M, Fusciello M, et al. Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids. J Immunother Cancer. 2021;9: pubmed publisher
	Sperk M, Mikaeloff F, Svensson Akusj xe4 rvi S, Krishnan S, Ponnan S, Ambikan A, et al. Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status. iScience. 2021;24:102111 pubmed publisher
	Wang K, Chen W, Zhang Z, Deng Y, Lian J, Du P, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5:283 pubmed publisher
	Wu J, Ma S, Sandhoff R, Ming Y, Hotz Wagenblatt A, Timmerman V, et al. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. Immunity. 2019;50:1218-1231.e5 pubmed publisher
	Saraiva D, Jacinto A, Borralho P, Braga S, Cabral M. HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy. Front Immunol. 2018;9:2605 pubmed publisher
	Awasthi S, Lubinski J, Shaw C, Barrett S, Cai M, Wang F, et al. Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compar. J Virol. 2011;85:10472-86 pubmed publisher

product information

Antigen :

CD8alpha

Apps. Abbrev. :

Cat # :

300922

Clone :

HIT8a

Item :

PerCP anti-human CD8a

Isotype :

Mouse IgG1, κ

Other Names :

T8, Leu2

Size :

100 tests

Price (USD) :

335 USD

Reactivity :

Human

Clonality :

Monoclonal

Host :

Mouse

Conjugate/Tag/Label :

PERCP

Application Notes :

Clone HIT8a recognizes the alpha chain of CD8^5. It does not block the binding of RPA-T8 antibody to CD8a.Additional reported applications of this antibody (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections^5,6. This clone was tested in-house and does not work on formalin fixed paraffin-embedded (FFPE) tissue.;

more info or order :

BioLegend product webpage